Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.
about
Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis.The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients.Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
P2860
Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Incidence and predictors of he ...... ated interferon and ribavirin.
@ast
Incidence and predictors of he ...... ated interferon and ribavirin.
@en
type
label
Incidence and predictors of he ...... ated interferon and ribavirin.
@ast
Incidence and predictors of he ...... ated interferon and ribavirin.
@en
prefLabel
Incidence and predictors of he ...... ated interferon and ribavirin.
@ast
Incidence and predictors of he ...... ated interferon and ribavirin.
@en
P2093
P2860
P1476
Incidence and predictors of he ...... ated interferon and ribavirin.
@en
P2093
A H Lashin
H M El-Feky
M A Metwally
Y A Shaheen
P2860
P2888
P304
P356
10.1007/S12664-013-0336-Z
P407
P577
2013-05-29T00:00:00Z
P6179
1031140192